CBPO

Q: What is the price of China Biologic Products (CBPO) today?

The current price of China Biologic Products (CBPO) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does China Biologic Products (CBPO) pay dividends?

China Biologic Products (CBPO) did not pay dividends over the past year.

China Biologic Products Holdings Inc.

Price

$ -

return (12m)

0.00%

p/e

30.56

p/bv

2.35

DIVIDEND YIELD

0.00%

CBPO price

CBPO

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment CBPO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals CBPO

review the fundamentals of China Biologic Products shares

P/E

30.56

Sector: -4.04 Industry: -4.04

P/S (PSR)

8.88

Sector: -3.86 Industry: -3.86

P/BV

2.35

Sector: 1.89 Industry: 1.89

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

6.74%

Sector: -61.23% Industry: -61.23%

ROE

7.68%

Sector: -60.44% Industry: -60.44%

ROIC

Sector: -1,165.26% Industry: -1,165.26%

NET MARGIN

29.04%

Sector: -39.16% Industry: -39.16%

GROSS MARGIN

65.68%

Sector: 37.91% Industry: 37.91%

OPERATING MARGIN

37.26%

Sector: -39.32% Industry: -39.32%

EV/EBITDA

21.74

Sector: -3.92 Industry: -3.92

EV/EBIT

24.91

Sector: -4.14 Industry: -4.14

PRICE-TO-ASSETS

2.06

Sector: 1.41 Industry: 1.41

BVPS

51.12

Sector: 1.88 Industry: 1.88

EPS

3.93

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

0.88

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.88

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF China Biologic Products ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 0.00

Fair Value

$ 0.00

Upside/Downside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals CBPO

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.05	6.75	25.92%	2.29%	$ 548.05 B	21.83%
PFE	19.76	1.65	8.35%	6.37%	$ 153.52 B	12.42%
ABBV	83.09	0.00	0.00%	3.35%	$ 351.12 B	6.91%
NVO	11.67	6.01	51.50%	4.53%	$ 182.84 B	33.05%
MRK	15.22	0.00	0.00%	2.97%	$ 277.74 B	28.08%
AZN	28.78	6.04	20.99%	1.69%	$ 294.30 B	17.41%
GILD	19.03	7.16	37.62%	2.45%	$ 161.96 B	28.90%
BMY	16.77	-3.48	-20.72%	4.28%	$ 118.31 B	14.64%
ZTS	19.15	15.37	80.25%	1.74%	$ 51.19 B	28.23%
REGN	17.18	2.48	14.41%	0.48%	$ 77.41 B	31.41%
HALO	24.34	158.01	649.21%	0.00%	$ 7.71 B	22.69%
AMGN	24.08	21.45	89.06%	2.80%	$ 185.71 B	20.98%
MCK	23.47	-1,028.86	-4,383.84%	0.38%	$ 101.86 B	1.09%
VRTX	27.65	5.86	21.18%	0.00%	$ 109.29 B	32.94%
HRMY	11.06	2.02	18.24%	0.00%	$ 1.76 B	18.27%
CAH	28.38	-17.47	-61.56%	1.02%	$ 47.16 B	0.68%
ADMA	18.24	5.61	30.78%	0.00%	$ 2.68 B	28.80%
BIIB	20.96	1.48	7.08%	0.00%	$ 27.10 B	13.07%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

CBPO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT China Biologic Products

China Biologic Products Holdings Inc.

Average Investor10 user rating

4.0 (0 people)

United States

37 years

Founded: 1989

2001

Time since IPO - 25 years

2.269

Employees

China Biologic Products Holdings Inc. (United States) is listed on the Nasdaq and has a market capitalization of $4.65 Billions, with shareholders equity totaling $1.98 Billion.

The company employs approximately 2.269 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, China Biologic Products Holdings Inc. reported $524.37 Millions in revenue, generating net income of $152.29 Millions.

Key financial metrics include a P/E ratio of 30.56, a price-to-book (P/B) ratio of 2.35, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CBPO.

Market cap

$ 4.65 Billions

Net worth

$ 1.98 Billion

$ 1,982,937,614.00

Assets

$ 2.26 Billions

$ 2,259,514,231.00

Total Shares Outstanding

38.79 Millions

38,788,000

Average Daily Trading Volume

$ 147.21 Thousand

$ 147,207.00

Sector

Health Care

Industry

Biotechnology

CBPO

CBPO revenue and profits

Financial Results CBPO

DRAG THE FRAME TO SEE MORE DATA

CBPO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 828.32 18,96% (12M)

P/E

23.47

0.38%

ROE

-4,383.84%

P/BV

-1,028.86

CAH - Cardinal Health

$ 202.34 48,02% (12M)

P/E

28.38

1.02%

ROE

-61.56%

P/BV

-17.47

JNJ - Johnson & Johnson

$ 225.34 49,98% (12M)

P/E

26.05

2.29%

ROE

25.92%

P/BV

6.75

PFE - Pfizer

$ 26.79 26,68% (12M)

P/E

19.76

6.37%

ROE

8.35%

P/BV

1.65

ABBV - AbbVie

$ 197.38 6,86% (12M)

P/E

83.09

3.35%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 110.23 37,32% (12M)

P/E

15.22

2.97%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 187.51 33,08% (12M)

P/E

28.78

1.69%

ROE

20.99%

P/BV

6.04

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 828.32 18,96% (12 M)

P/L

23.47

0.38%

ROE

-4,383.84%

P/VP

-1,028.86

CAH - Cardinal Health

$ 202.34 48,02% (12 M)

P/L

28.38

1.02%

ROE

-61.56%

P/VP

-17.47

JNJ - Johnson & Johnson

$ 225.34 49,98% (12 M)

P/L

26.05

2.29%

ROE

25.92%

P/VP

6.75

PFE - Pfizer

$ 26.79 26,68% (12 M)

P/L

19.76

6.37%

ROE

8.35%

P/VP

1.65

ABBV - AbbVie

$ 197.38 6,86% (12 M)

P/L

83.09

3.35%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 110.23 37,32% (12 M)

P/L

15.22

2.97%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 187.51 33,08% (12 M)

P/L

28.78

1.69%

ROE

20.99%

P/VP

6.04

Frequently Asked Questions

What is the price of China Biologic Products (CBPO) today?

The current price of China Biologic Products (CBPO) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does China Biologic Products (CBPO) pay dividends?

China Biologic Products (CBPO) did not pay dividends over the past year.

Is China Biologic Products (CBPO) a good investment?

China Biologic Products (CBPO) is currently trading at $ 0.00 with a P/E ratio of 30.56%. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy China Biologic Products (CBPO) stock?

You can buy China Biologic Products (CBPO) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol CBPO and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of China Biologic Products (CBPO) yield today?

Over the past month, China Biologic Products (CBPO) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of China Biologic Products (CBPO) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CBPO

China Biologic Products Holdings Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CBPO

review the fundamentals of China Biologic Products shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT China Biologic Products

China Biologic Products Holdings Inc.

United States

37 years

2001

2.269

PROFIT X PRICE CBPO

Financial Results CBPO

CBPO cash flow

Asset, Revenue and Profit Growth - CBPO

CBPO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions